MEI Pharma Reports Fiscal Year 2023 Results and Operational Highlights - MEI Pharma (NASDAQ:MEIP)

-- Conference Call Today at 5:00 p.m. Eastern Time -- MEI Pharma, Inc. (NASDAQ:MEIP), a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, today reported results for its fiscal year

Related Keywords

United States ,Japan ,Davidm Urso , ,Pharma Inc ,Drug Administration ,Safety Review Committee Of The Phase ,Infinity Pharmaceuticals ,Linkedin ,Company Special Meeting Of Stockholders ,Devices Agency ,Nasdaq ,Call Today ,Special Meeting ,Jay File ,Brian Drazba ,Safety Review Committee ,Kyowa Kirin ,Medical Devices Agency ,Commercialization Agreement ,Private Securities Litigation Reform Act ,